Elekta (OTCMKTS:EKTAY) Shares Gap Up – Time to Buy?

Elekta AB (OTCMKTS:EKTAYGet Free Report)’s stock price gapped up before the market opened on Monday . The stock had previously closed at $5.12, but opened at $5.40. Elekta shares last traded at $5.39, with a volume of 380 shares.

Wall Street Analysts Forecast Growth

Separately, Zacks Research upgraded shares of Elekta from a “strong sell” rating to a “hold” rating in a report on Tuesday, July 28th. One equities research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company has an average rating of “Reduce”.

View Our Latest Report on Elekta

Elekta Stock Up 2.1%

The firm’s 50-day simple moving average is $5.16 and its 200 day simple moving average is $5.78. The company has a debt-to-equity ratio of 0.47, a quick ratio of 0.68 and a current ratio of 0.87. The stock has a market capitalization of $1.99 billion, a P/E ratio of -33.69 and a beta of 1.01.

Elekta (OTCMKTS:EKTAYGet Free Report) last posted its quarterly earnings data on Thursday, May 28th. The company reported $0.06 EPS for the quarter. The company had revenue of $521.00 million during the quarter. Elekta had a negative net margin of 3.32% and a positive return on equity of 11.11%. As a group, research analysts expect that Elekta AB will post 0.43 EPS for the current year.

Elekta Company Profile

(Get Free Report)

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.

Read More

Receive News & Ratings for Elekta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elekta and related companies with MarketBeat.com's FREE daily email newsletter.